UPDATE: Lion Licenses SRS Platform to Affymetrix | GenomeWeb

This story has been updated from a previous version.

NEW YORK, May 17 - Lion Bioscience has licensed its SRS platform to Affymetrix for use in internal R&D as well as for a customer portal, Lion said Thursday.

The licensing deal will be for three years, Jan Mous, chief scientific officer of Lion, told GenomeWeb. No other terms of the agreement were disclosed, though Mous did call the size of the deal  "larger than usual" for Lion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.